Acute Myeloid Leukemia — Trials

Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,962 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 789
Recruiting: 466
Ph III recruiting: 45
Growth YoY: +5%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (534)

clinicaltrialsPublishedShowing 201–250 of 528 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03050268	Familial Investigations of Childhood Cancer Predisposition(SJFAMILY)	recruiting	—	1,500	St. Jude Children's Research HospitalOTHER	1	Jun 17, 2026	clinicaltrials
NCT03113643	SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)	recruiting	Phase 1	72	Dana-Farber Cancer InstituteOTHER